Breaking Corporate Events, Analysed in Real Time

Emcure Pharmaceuticals Crosses $1 Billion Revenue Milestone as FY26 PAT Surges 41%

Emcure Pharmaceuticals achieved a significant milestone in FY26 by surpassing $1 billion in annual revenue, driven by a 16.6% growth in total income. The company reported a robust 41% increase in adjusted PAT, underpinned by strong expansion in international markets and a resilient domestic portfolio.

Emcure Pharmaceuticals Achieves ₹9,204 Cr Revenue Milestone; Targets Margin Growth in FY27

Emcure Pharmaceuticals surpassed the $1 billion revenue milestone in FY26, driven by a 22.2% surge in international markets. While domestic restructuring led to a temporary Q4 slowdown in the Zuventus portfolio, management has guided for margin expansion and steady growth for FY27.